Status:
COMPLETED
Non Interventional Study For Patients Treated With Somavert®
Lead Sponsor:
Pfizer
Conditions:
Acromegaly
Eligibility:
All Genders
18+ years
Brief Summary
This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in tre...
Detailed Description
Non probability samples
Eligibility Criteria
Inclusion
- Subjects with diagnosed acromegaly who were already being treated with Somavert® or were to start treatment with Somavert® were included in the study.
Exclusion
- Subjects treated with an investigational drug for treatment of acromegaly.
- Subjects with symptoms such visual field loss, cranial nerve palsies or intracranial hypertension, indicating need for surgery.
- Women who were pregnant or lactating.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT00858143
Start Date
January 1 2004
End Date
January 1 2008
Last Update
September 2 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.